Skip to main content
Log in

Effect of L-carnitine on cardiomyocyte apoptosis and cardiac function in patients undergoing heart valve replacement operation

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The effects of L-carnitine, as an ingredient of cardioplegia solution, on cardiac function and cardiomyocyte apoptosis in patients undergoing heart valve replacement operation were investigated. Twenty-three cases undergoing heart valve replacement with cardiopulmonary bypass (CPB) were randomly allocated into two groups: L-carnitine group (n=12, 12 g/L L-carnitine was put in the ST. Thomas cardioplegia) and control group (n=11, identical to the L-carnitine group except that normal saline was administered instead of L-carnitine). Serum cardial troponin I (cTnI) levels, the left ventricular ejection fraction (LVEF), and cardiac index (CI) were measured perioperatively. A bit of myocardial tissue obtained from right atria was taken before CPB and by the end of intracardiac procedure to undergo electron microscopy examination and estimate apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL). From the end of CPB to 3 days after operation, the serum levels of cTnI in the L-carnitine group was significantly lower than that in the control group (P<0.05). Heart color ultrasonogram showed that the CI index and LVEF at 7th day postoperatively in the L-carnitine group were significantly higher than in the control group (P<0.05). Compared to the control group, L-carnitine significantly alleviated the morphologic changes of cardiac muscle cells (electron microscopy examination) and decreased the amounts of apoptotic cardiac muscle cells (TUNEL). Furthermore, the dosage of vasoactive drugs used after operation was significantly less in the L-carnitine group (P<0.01). It was concluded that L-carnitine cardioplegia solution could improve cardiac function in patients undergoing heart valve replacement operation and alleviate CPB-mediated apoptosis of cardiac muscle cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nemoto S, Yasuhara K, Nakamura Ket al. Plasma carnitine concentrations in patients undergoing open heart surgery. Ann Thorac Cardiovasc Surg, 2004,10: 19

    PubMed  Google Scholar 

  2. Zaugg C E, Spaniol M, Kaufmann Pet al. Myocardial function and energy metabolism in carnitine-deficient rats. Cell Mol Life Sci, 2003,60:767

    Article  PubMed  CAS  Google Scholar 

  3. Pastoris O, Dossena M, Foppa P,et al. Effect of L-carnitine on myocardial metabolism: results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery. Pharmacol Res, 1998,37(2):115

    Article  PubMed  CAS  Google Scholar 

  4. Cavrieli Y, Sherman Y, Ben-Sasson S A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol, 1992,119:493

    Article  Google Scholar 

  5. Stadler B, Phillips J, Toyoda Yet al. Adenosine enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia reperfusion. Ann Thorac Surg, 2001,72:555

    Article  PubMed  CAS  Google Scholar 

  6. Lopez J R, Jahangir R, Jahangir Aet al. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg, 1996,112,820

    Article  PubMed  CAS  Google Scholar 

  7. Carvajal K, Moreno-Sanchez R. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res, 2003,34:89

    Article  PubMed  CAS  Google Scholar 

  8. Evangeliou A, Vlassopoulos D. Carnitine metabolism and deficit—when supplementation is necessary? Curr Pharm Biotechnol, 2003,4:211

    Article  PubMed  CAS  Google Scholar 

  9. Buerke M, Murohara T, Skurk Cet al. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A, 1995, 15(92):8031

    Article  Google Scholar 

  10. Gottlieb R A, Burleson K O, Kloner R Aet al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest, 1994,94:1621

    Article  PubMed  CAS  Google Scholar 

  11. Yeh C H, Wang Y C, Wu Y Cet al. Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis. Chest, 2003,123:1647

    Article  PubMed  Google Scholar 

  12. Fringuelli R, Utrilla Navarro M P, Milanese Let al. Synthesis and evaluation of anti-apoptotic activity of L-carnitine cyclic analogues and amino acid derivatives. Farmaco, 2004,59:271

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiang Daokang.

Additional information

XIANG Daokang, male, born in 1968, Associate Professor

This project was supported by a grant from Guizhou Provincial Natural Sciences Foundation (No. 2003-C03-1).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daokang, X., Zongquan, S., Jiahong, X. et al. Effect of L-carnitine on cardiomyocyte apoptosis and cardiac function in patients undergoing heart valve replacement operation. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 25, 501–504 (2005). https://doi.org/10.1007/BF02895999

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02895999

Key words

Navigation